Medical Device News Magazine

Broken String Biosciences appoints Gavin Burns as Vice President of Quality and Operations

Experienced quality assurance professional joins team to support ongoing strategic growth plans as the Company expands access and capabilities of INDUCE-seq DNA break mapping platform

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Broken String Biosciences (“Broken String”), a genomics company that has built a technology platform to drive the development of cell and gene therapies that are safer by design, today announced the appointment of Gavin Burns, PhD, as Vice President of Quality and Operations.

With an extensive background leading quality assurance in the genomics sector, Gavin will be responsible for building and optimizing Broken String’s teams, processes, and systems. His appointment will enable the Company to develop and scale its Next Generation Sequencing (NGS)-based DNA break-mapping platform, INDUCE-seq™, furthering the technology’s capabilities in supporting gene-editing applications.

Gavin brings over 20 years’ experience in research, operations, and quality assurance from across the genomics sector to Broken String, including as Associate Director of Quality at Illumina, where he provided pivotal support on the set up and operations for the accredited Illumina Laboratory Services in the UK, enabling them to provide the sequencing services for the successful NHS/Genomics England 100,000-genome project. Prior to joining Broken String, Gavin held senior quality and operational roles at several UK-based start-ups, most recently serving as Director of Quality and Operations at Biocrucible. In this position, Gavin led expansion of staff, facilities, and processes, including rapid implementation of an ISO 13485 quality management system. He holds a PhD in Genomics from the British Antarctic Survey, Cambridge, and Gothenburg University, Sweden.

Felix Dobbs, PhD, Chief Executive Officer at Broken String Biosciences, commented: “Gavin’s expertise in quality strategy and implementing robust processes will be key to executing our growth plans as part of our Series A goals. As well as supporting scale-up operations in these areas, Gavin will ensure that our INDUCE-seq platform meets the quality needs of our partners who are developing the next generation of transformative gene editing therapies. We are thrilled to have Gavin on board as we build towards a future where gene editing therapies can be safely delivered to all who need it.”

Gavin Burns, PhD, VP Quality and Operations at Broken String Biosciences, said: “The INDUCE-seq technology offered by Broken String Biosciences has the potential to transform development of gene edited cell and gene therapies. I look forward to working closely with the rest of the team at Broken String Biosciences to support scale-up and growth at this exciting time, and ensure processes are optimized so that we can continue to deliver high quality and cutting-edge technology that meets the needs of our customers.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.